27,102 reports of this reaction
1.8% of all ADALIMUMAB reports
#8 most reported adverse reaction
NAUSEA is the #8 most commonly reported adverse reaction for ADALIMUMAB, manufactured by AbbVie Inc.. There are 27,102 FDA adverse event reports linking ADALIMUMAB to NAUSEA. This represents approximately 1.8% of all 1,482,766 adverse event reports for this drug.
Patients taking ADALIMUMAB who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is a less commonly reported adverse event for ADALIMUMAB, but still significant enough to appear in the safety profile.
In addition to nausea, the following adverse reactions have been reported for ADALIMUMAB:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 27,102 FDA reports for ADALIMUMAB. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 1.8% of all adverse event reports for ADALIMUMAB, making it a notable side effect.
If you experience nausea while taking ADALIMUMAB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.